Role of Glucose-Lowering Medications in Erectile Dysfunction
Erectile dysfunction (ED) is a long-term complication of type 2 diabetes (T2D) widely known to affect the quality of life. Several aspects of altered metabolism in individuals with T2D may help to compromise the penile vasculature structure and functions, thus exacerbating the imbalance between smoo...
Main Authors: | Angelo Cignarelli, Valentina Annamaria Genchi, Rossella D’Oria, Fiorella Giordano, Irene Caruso, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2501 |
Similar Items
-
Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine?
by: Valentina Annamaria Genchi, et al.
Published: (2021-06-01) -
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies
by: Irene Caruso, et al.
Published: (2022-02-01) -
The p66<sup>Shc</sup> Redox Protein and the Emerging Complications of Diabetes
by: Giuseppina Biondi, et al.
Published: (2023-12-01) -
Relationship Between Triglyceride-Glucose Index and Erectile Dysfunction in Subjects Without Cardiovascular Disease
by: Ersan Oflar, et al.
Published: (2023-05-01) -
Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity
by: Nicola Marrano, et al.
Published: (2021-02-01)